摘要
注意力缺陷和多动症(ADHD)症状的特征在于粗心和极度活跃。它是一种常见的儿童神经发育障碍,往往持续到成年。用精神振奋药物改善ADHD症状被认为是一种矛盾的镇静作用。精神兴奋药盐酸哌甲酯控制片(MPH)目前被用作治疗ADHD的一线药物。最近的研究提到注意改变多巴胺介导的神经传递多动症,特别是通过多巴胺转运蛋白(DAT)的再摄取。这种假设是由观察到的DAT基因敲除小鼠表现出的显著极度活跃所支持,这种极度活跃对急性MPH治疗敏感。但是,其他与多动症有关行为尚未完全阐明。在本研究中,我们观察到了DAT基因敲除小鼠在新环境中的梭箱回避行为和极度活跃的学习障碍。盐酸哌甲酯控释片使这些行为正常化且增加大鼠悬尾实验中的躲避行为。有趣的是,有效剂量的MPH增加前额皮质的细胞外多巴胺,而不增加纹状体的,说明在ADHD中前额多巴胺的改变重要性。运用啮齿动物模型如DAT敲除小鼠的研究可能对阐明多动症的病理生理学有用。
关键词: ADHD,多巴胺转运蛋白,额叶皮质,敲除,学习,哌醋甲酯,去甲肾上腺素转运蛋白
Current Molecular Medicine
Title:Improvement of Learning and Increase in Dopamine Level in the Frontal Cortex by Methylphenidate in Mice Lacking Dopamine Transporter
Volume: 15 Issue: 3
Author(s): Y. Takamatsu, Y. Hagino, A. Sato, T. Takahashi, S.Y. Nagasawa, Y. Kubo, M. Mizuguchi, G.R. Uhl, I. Sora and K. Ikeda
Affiliation:
关键词: ADHD,多巴胺转运蛋白,额叶皮质,敲除,学习,哌醋甲酯,去甲肾上腺素转运蛋白
摘要: The symptoms of attention-deficit/hyperactivity disorder (ADHD) are characterized by inattention and hyperactivity-impulsivity. It is a common childhood neurodevelopmental disorder that often persists into adulthood. Improvements in ADHD symptoms using psychostimulants have been recognized as a paradoxical calming effect. The psychostimulant methylphenidate (MPH) is currently used as the first-line medication for the management of ADHD. Recent studies have drawn attention to altered dopamine-mediated neurotransmission in ADHD, particularly reuptake by the dopamine transporter (DAT). This hypothesis is supported by the observation that DAT knockout mice exhibit marked hyperactivity that is responsive to acute MPH treatment. However, other behaviors relevant to ADHD have not been fully clarified. In the present study, we observed learning impairment in shuttle-box avoidance behavior together with hyperactivity in a novel environment in DAT knockout mice. Methylphenidate normalized these behaviors and enhanced escape activity in the tail suspension test. Interestingly, the effective dose of MPH increased extracellular dopamine in the prefrontal cortex but not striatum, suggesting an important role for changes in prefrontal dopamine in ADHD. Research that uses rodent models such as DAT knockout mice may be useful for elucidating the pathophysiology of ADHD.
Export Options
About this article
Cite this article as:
Y. Takamatsu, Y. Hagino, A. Sato, T. Takahashi, S.Y. Nagasawa, Y. Kubo, M. Mizuguchi, G.R. Uhl, I. Sora and K. Ikeda , Improvement of Learning and Increase in Dopamine Level in the Frontal Cortex by Methylphenidate in Mice Lacking Dopamine Transporter, Current Molecular Medicine 2015; 15 (3) . https://dx.doi.org/10.2174/1566524015666150330144018
DOI https://dx.doi.org/10.2174/1566524015666150330144018 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Treatment of Catatonia with Asenapine in a Patient with Schizotypal Personality Disorder, Psychotic Depression and Septic Shock from SARSCoV- 2 - A Case Report
CNS & Neurological Disorders - Drug Targets The Role of Oxidative Stress in Huntington’s Disease: Are Antioxidants Good Therapeutic Candidates?
Current Drug Targets Alzheimer's Disease: Related Targets, Synthesis of Available Drugs, Bioactive Compounds Under Development and Promising Results Obtained from Multi-target Approaches
Current Drug Targets The Expanding Universe of Neurotrophic Factors: Therapeutic Potential in Aging and Age-Associated Disorders
Current Pharmaceutical Design Quantitative Molecular Imaging of Neuronal Nicotinic Acetylcholine Receptors in the Human Brain with A-85380 Radiotracers
Current Medical Imaging Seeing Genes at Work in the Living Brain with Non-Invasive Molecular Imaging
Current Gene Therapy Nitric Oxide’s Involvement in the Spectrum of Psychotic Disorders
Current Medicinal Chemistry Vanilloid Transient Receptor Potential Cation Channels: An Overview
Current Pharmaceutical Design Spatiotemporal Gait Characteristics Associated with Cognitive Impairment: A Multicenter Cross-Sectional Study, the Intercontinental “Gait, cOgnitiOn & Decline” Initiative
Current Alzheimer Research Quantitative Gait Disturbances in Older Adults with Cognitive Impairments
Current Pharmaceutical Design Functional Cross-Talk between Adenosine and Metabotropic Glutamate Receptors
Current Neuropharmacology Endothelium and Oxidative Stress: The Pandora's Box of Cerebral (and Non-Only) Small Vessel Disease?
Current Molecular Medicine Runx2/Cbfa1: A Multifunctional Regulator of Bone Formation
Current Pharmaceutical Design The Roles of Neurotensin and its Analogues in Pain
Current Pharmaceutical Design Time Perception Distortion in Neuropsychiatric and Neurological Disorders
CNS & Neurological Disorders - Drug Targets GSK-3 Inhibitors: A New Class of Drugs for Alzheimer’s Disease Treatment
Current Drug Targets Perinatal Brain Injury
Current Pediatric Reviews The Therapeutic Potential of Sigma (σ) Receptors for the Treatment of Central Nervous System Diseases: Evaluation of the Evidence
Current Pharmaceutical Design Review on the Protective Effects of PACAP in Models of Neurodegenerative Diseases In Vitro and In Vivo
Current Pharmaceutical Design Applications of Arterial Spin Labelling in Mild Cognitive Impairment, Alzheimers Disease and Other Forms of Dementia
Current Medical Imaging